Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
October 16, 2025 Off

Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements

By GlobeNewswire

WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…

October 16, 2025 Off

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million

By GlobeNewswire

WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…

October 16, 2025 Off

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

By GlobeNewswire

SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…

October 16, 2025 Off

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

By GlobeNewswire

SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company…

October 16, 2025 Off

Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest

By GlobeNewswire

Company intends to collaborate with government initiatives, Long COVID patient organizations, and major healthcare providers to expedite development of TVGN…

October 16, 2025 Off

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation

By GlobeNewswire

Nasdaq Hearing Cancellation and Continued ListingFOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or…

October 16, 2025 Off

OSE Immunotherapeutics Reports First Half 2025 Financial Results

By GlobeNewswire

OSE Immunotherapeutics Reports First Half 2025 Financial Results NANTES, France, October 15, 2025 – 7:00pm CET – OSE Immunotherapeutics SA…

October 16, 2025 Off

IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2025

By GlobeNewswire

Aggregated presentation by day and by marketStatement of transactions in own shares from October 06th to October 10th 2025       Name of…

October 16, 2025 Off

Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic

By GlobeNewswire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE…

October 16, 2025 Off

Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”

By GlobeNewswire

Recognition for groundbreaking work and pioneering space manufacturingBOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) — Fast Company has named Eascra Biotech,…

Posts pagination

Previous 1 … 71 72 73 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine